Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples